TCG Crossover GP II, LLC - 03 Feb 2026 SCHEDULE 13G Report for Perspective Therapeutics, Inc. Common Stock, $0.001 par value (CATX)

Filing Manager
TCG Crossover GP II, LLC
Reporting Manager
Chen Yu
Security
Perspective Therapeutics, Inc. Common Stock, $0.001 par value
Symbol
CATX
Shares outstanding
114,718,362 shares
Disclosed Ownership
7,915,567 shares
Ownership
6.9%
Form type
SCHEDULE 13G
Filing time
06 Feb 2026, 16:45:05 UTC
Date of event
03 Feb 2026
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"TCG Crossover GP II, LLC disclosed 6.9% ownership in Perspective Therapeutics, Inc. Common Stock, $0.001 par value (CATX) on 03 Feb 2026."

Quick Takeaways

  • TCG Crossover GP II, LLC filed SCHEDULE 13G for Perspective Therapeutics, Inc. Common Stock, $0.001 par value (CATX).
  • Disclosed ownership: 6.9%.
  • Date of event: 03 Feb 2026.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 06 Feb 2026, 16:45.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (5)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
TCG Crossover GP II, LLC 3.5% 3,957,784 0 3,957,784 /s/ Craig Skaling Craig Skaling, Authorized Signatory
TCG Crossover Fund II, L.P. 3.5% 3,957,784 0 3,957,784 /s/ Craig Skaling Craig Skaling, Authorized Signatory
TCG Crossover GP III, LLC 3.5% 3,957,783 0 3,957,783 /s/ Craig Skaling Craig Skaling, Authorized Signatory
TCG Crossover Fund III, L.P. 3.5% 3,957,783 0 3,957,783 /s/ Craig Skaling Craig Skaling, Authorized Signatory
Chen Yu 6.9% 7,915,567 0 7,915,567 /s/ Craig Skaling Craig Skaling, as Attorney-in-Fact for Chen Yu

Sponsored